Literature DB >> 20298221

Caenorhabditis elegans: a useful tool to decipher neurodegenerative pathways.

James R Johnson1, Robert C Jenn, Jeff W Barclay, Robert D Burgoyne, Alan Morgan.   

Abstract

Neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's diseases affect millions of people. These disorders are age-dependent, progressive and, at present, incurable. A practical and relevant model is needed to investigate the molecular determinants of these debilitating diseases. Mammalian models are often prohibitively expensive, time-consuming and very complex. Given the highly conserved neurological pathways between mammals and invertebrates, Caenorhabditis elegans has emerged as a powerful tool for the investigation of the pathophysiology of these disorders. We describe recent findings in this area and show how C. elegans is being used to broaden our knowledge of human neurodegenerative diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20298221     DOI: 10.1042/BST0380559

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

1.  Cranberry Extract Standardized for Proanthocyanidins Alleviates β-Amyloid Peptide Toxicity by Improving Proteostasis Through HSF-1 in Caenorhabditis elegans Model of Alzheimer's Disease.

Authors:  Hong Guo; Min Cao; Sige Zou; Boping Ye; Yuqing Dong
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-23       Impact factor: 6.053

Review 2.  Structural aspects of the aging invertebrate brain.

Authors:  Sandra C Koch; Annie Nelson; Volker Hartenstein
Journal:  Cell Tissue Res       Date:  2021-01-06       Impact factor: 5.249

3.  Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms.

Authors:  Xi Chen; Robert D Burgoyne
Journal:  BMC Genomics       Date:  2012-02-14       Impact factor: 3.969

4.  Expression profile of a Caenorhabditis elegans model of adult neuronal ceroid lipofuscinosis reveals down regulation of ubiquitin E3 ligase components.

Authors:  Hannah V McCue; Xi Chen; Jeff W Barclay; Alan Morgan; Robert D Burgoyne
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

5.  Microfluidic Device to Measure the Speed of C. elegans Using the Resistance Change of the Flexible Electrode.

Authors:  Jaehoon Jung; Masahiro Nakajima; Masaru Takeuchi; Zoran Najdovski; Qiang Huang; Toshio Fukuda
Journal:  Micromachines (Basel)       Date:  2016-03-19       Impact factor: 2.891

6.  Liuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegans.

Authors:  Jatinder S Sangha; Xiaoli Sun; Owen S D Wally; Kaibin Zhang; Xiuhong Ji; Zhimin Wang; Yanwen Wang; Jeffrey Zidichouski; Balakrishnan Prithiviraj; Junzeng Zhang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

7.  Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol.

Authors:  Sudhanva S Kashyap; James R Johnson; Hannah V McCue; Xi Chen; Matthew J Edmonds; Mimieveshiofuo Ayala; Margaret E Graham; Robert C Jenn; Jeff W Barclay; Robert D Burgoyne; Alan Morgan
Journal:  Hum Mol Genet       Date:  2014-06-19       Impact factor: 6.150

8.  A Cultivated Form of a Red Seaweed (Chondrus crispus), Suppresses β-Amyloid-Induced Paralysis in Caenorhabditis elegans.

Authors:  Jatinder Singh Sangha; Owen Wally; Arjun H Banskota; Roumiana Stefanova; Jeff T Hafting; Alan T Critchley; Balakrishnan Prithiviraj
Journal:  Mar Drugs       Date:  2015-10-20       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.